Accel Clinical

Largo, Florida 33777

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus

Studies at this site

• A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus — Completed